Status:
COMPLETED
Diabetic Patients,Self-Efficacy,Self-Care Behaviors,Artificial Intelligence-Based
Lead Sponsor:
Chia-Tzu Line
Conditions:
Diabetic Patients,Self-Care,Artificial Intelligence-Based,Self-Efficacy
Type 2 Diabetes Mellitus (T2DM)
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study employed an experimental research design using a randomized controlled trial methodology. Group allocation was performed randomly by generating serial numbers through a computer. Participan...
Eligibility Criteria
Inclusion
- Diagnosed with type 2 diabetes by a physician and enrolled as a patient in the Diabetes Collaborative Care Network.
- Aged 18 years or older.
- Owns a smartphone and agrees to join the "Diabetes Smart Helper" LINE@ Diabetes Health Education Chatbot application.
- HbA1c level greater than 7.0% (as referenced in Changsieng et al., 2023; Selçuk-Tosun \& Zincir, 2019).
Exclusion
- Patients undergoing hemodialysis or peritoneal dialysis.
- Patients diagnosed with mental illness.
- Illiterate patients.
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06985680
Start Date
February 1 2024
End Date
February 18 2025
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wei Gong Memorial Hospital
Taiwan, Toufen City, China, 350